Grant: Project Grant
Ottawa Hospital Research Institute
$822,375.00
The role of Nox5 in hypertension-associated renal injury
EF 2018-19
Résumé
High blood pressure is the 2nd leading cause of kidney disease. We are investigating how high blood pressure through an abnormal level of oxygen based molecules, called oxidative stress, damages the kidney and its ability to function normally. In particular, we have identified an enzyme, called Nox5, that contributes to oxidative stress in the kidney. We propose that Nox5, when its levels are increased in high blood pressure, contributes to the ongoing elevation in blood pressure and causes damage to the kidney. As such, we believe that Nox5 could become a target for future drugs that would help prevent or treat hypertension associated kidney disease.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
389140
Name
Kennedy Christopher R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Hematology, Digestive Disease & Kidney
Projecttitle
The role of Nox5 in hypertension-associated renal injury
Programtype2
Operating Grants
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$822,375
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Angiotensin Ii; Chronic Kidney Disease; Hypertension; Inflammation; Macrophages; Nox5; Oxidative Stress; Transgenic Mice
Abstract
High blood pressure is the 2nd leading cause of kidney disease. We are investigating how high blood pressure through an abnormal level of oxygen based molecules, called oxidative stress, damages the kidney and its ability to function normally. In particular, we have identified an enzyme, called Nox5, that contributes to oxidative stress in the kidney. We propose that Nox5, when its levels are increased in high blood pressure, contributes to the ongoing elevation in blood pressure and causes damage to the kidney. As such, we believe that Nox5 could become a target for future drugs that would help prevent or treat hypertension associated kidney disease.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Kennedy, Christopher R
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $822,375~ $0~